Atlas Trials

Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock

Clinical trial NCT00534287 · COMPLETED

Trial details

NCT number
NCT00534287
Sponsor
Kompetenznetz Sepsis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Severe SepsisSeptic Shock
Start date
2007-10-01
Primary completion
2010-04-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.